Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Khiron Life Sciences Corp. stock logo
KHRN
Khiron Life Sciences
C$0.04
C$0.04
C$0.04
C$0.21
C$9.30M2.64256,268 shs24,000 shs
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
C$0.08
+7.1%
C$0.09
C$0.06
C$0.12
C$31.13M0.88352,075 shs509,256 shs
Meta Platforms, Inc. stock logo
META
Meta Platforms
$670.89
+3.6%
$578.56
$442.65
$740.91
$1.69T1.2414.48 million shs12.46 million shs
Zomedica Corp. stock logo
ZOM
Zomedica
$0.12
$0.09
$0.17
$95.35M1.034.46 million shs790,936 shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Khiron Life Sciences Corp. stock logo
KHRN
Khiron Life Sciences
0.00%0.00%0.00%0.00%0.00%
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
0.00%0.00%-11.76%0.00%-6.25%
Meta Platforms, Inc. stock logo
META
Meta Platforms
0.00%+2.42%+7.57%-1.96%+37.57%
Zomedica Corp. stock logo
ZOM
Zomedica
0.00%0.00%0.00%0.00%-41.51%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Khiron Life Sciences Corp. stock logo
KHRN
Khiron Life Sciences
N/AN/AN/AN/AN/AN/AN/AN/A
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
N/AN/AN/AN/AN/AN/AN/AN/A
Meta Platforms, Inc. stock logo
META
Meta Platforms
3.3715 of 5 stars
2.53.01.70.02.93.31.9
Zomedica Corp. stock logo
ZOM
Zomedica
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Khiron Life Sciences Corp. stock logo
KHRN
Khiron Life Sciences
0.00
N/AN/AN/A
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
0.00
N/AN/AN/A
Meta Platforms, Inc. stock logo
META
Meta Platforms
2.91
Moderate Buy$701.055.70% Upside
Zomedica Corp. stock logo
ZOM
Zomedica
4.00
Strong BuyN/AN/A

Current Analyst Ratings Breakdown

Latest KHRN, ZOM, META, and LABS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/16/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$695.00 ➝ $888.00
5/1/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$740.00 ➝ $740.00
5/1/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$624.00 ➝ $676.00
5/1/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$705.00 ➝ $640.00
5/1/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$752.00 ➝ $664.00
5/1/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
TD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$725.00 ➝ $700.00
5/1/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetPositive ➝ Positive$800.00 ➝ $700.00
5/1/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$675.00 ➝ $725.00
5/1/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$650.00 ➝ $683.00
5/1/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy$580.00 ➝ $620.00
(Data available from 6/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Khiron Life Sciences Corp. stock logo
KHRN
Khiron Life Sciences
C$18.08M0.51C$0.01 per share6.67C$0.20 per share0.20
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
C$39.42M0.79C$0.06 per share1.30C$0.11 per share0.68
Meta Platforms, Inc. stock logo
META
Meta Platforms
$170.36B9.79$29.33 per share22.61$72.08 per share9.20
Zomedica Corp. stock logo
ZOM
Zomedica
$25.19M0.00N/AN/A$0.24 per share0.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Khiron Life Sciences Corp. stock logo
KHRN
Khiron Life Sciences
-C$46.80M-C$0.20N/AN/A-258.92%-68.62%-20.79%N/A
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
-C$12.05M-C$0.03N/AN/A-30.56%-24.41%-7.17%N/A
Meta Platforms, Inc. stock logo
META
Meta Platforms
$62.36B$25.6427.6921.951.4237.91%38.17%25.31%7/30/2025 (Estimated)
Zomedica Corp. stock logo
ZOM
Zomedica
-$34.53M-$0.06N/AN/AN/A-232.88%-12.47%-11.84%N/A

Latest KHRN, ZOM, META, and LABS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/30/2025Q1 2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
$5.33$6.43+$1.10$6.43$41.45 billion$42.31 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Khiron Life Sciences Corp. stock logo
KHRN
Khiron Life Sciences
N/AN/AN/AN/AN/A
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
N/AN/AN/AN/AN/A
Meta Platforms, Inc. stock logo
META
Meta Platforms
$2.100.32%N/A8.19%1 Years
Zomedica Corp. stock logo
ZOM
Zomedica
N/AN/AN/AN/AN/A

Latest KHRN, ZOM, META, and LABS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/29/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
quarterly$0.52500.33%6/16/20256/16/20256/26/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Khiron Life Sciences Corp. stock logo
KHRN
Khiron Life Sciences
6.68
3.08
0.72
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
1.45
3.21
3.10
Meta Platforms, Inc. stock logo
META
Meta Platforms
0.16
2.98
2.98
Zomedica Corp. stock logo
ZOM
Zomedica
N/A
10.82
10.15

Institutional Ownership

CompanyInstitutional Ownership
Khiron Life Sciences Corp. stock logo
KHRN
Khiron Life Sciences
0.22%
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
0.71%
Meta Platforms, Inc. stock logo
META
Meta Platforms
79.91%
Zomedica Corp. stock logo
ZOM
Zomedica
8.95%

Insider Ownership

CompanyInsider Ownership
Khiron Life Sciences Corp. stock logo
KHRN
Khiron Life Sciences
4.64%
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
4.45%
Meta Platforms, Inc. stock logo
META
Meta Platforms
13.61%
Zomedica Corp. stock logo
ZOM
Zomedica
4.19%
CompanyEmployeesShares OutstandingFree FloatOptionable
Khiron Life Sciences Corp. stock logo
KHRN
Khiron Life Sciences
N/A232.41 millionN/ANot Optionable
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
130415.00 millionN/ANot Optionable
Meta Platforms, Inc. stock logo
META
Meta Platforms
86,5002.51 billion2.19 billionOptionable
Zomedica Corp. stock logo
ZOM
Zomedica
50979.95 million938.89 millionNot Optionable

Recent News About These Companies

15 Cheapest Stocks Insiders Are Buying In March
Q4 2024 Zomedica Corp Earnings Call
Zomedica (ZOMDF) Gets a Buy from Noble Financial
Zomedica Corp.
Zomedica Corp (ZOM) Stock Trading Recap

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Khiron Life Sciences stock logo

Khiron Life Sciences CVE:KHRN

C$0.04 0.00 (0.00%)
As of 05/5/2023

Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.

MediPharm Labs stock logo

MediPharm Labs TSE:LABS

C$0.08 +0.01 (+7.14%)
As of 02:45 PM Eastern

MediPharm Labs Corp, along with its subsidiaries, produces purified, pharmaceutical-like cannabis extracts and related derivative products. The company generates revenue from Private label, White label, the Tolling process, and others. Some of its vape brands are Northern Lights, Blue Dream Pink Kush and GG4. Its geographical segments are Canada and Australia.

Meta Platforms stock logo

Meta Platforms NASDAQ:META

$670.89 +23.40 (+3.61%)
Closing price 03:59 PM Eastern
Extended Trading
$671.33 +0.44 (+0.07%)
As of 04:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Meta Platforms, Inc. engages in the development of products that enable people to connect and share with friends and family through mobile devices, personal computers, virtual reality headsets, and wearables worldwide. It operates in two segments, Family of Apps and Reality Labs. The Family of Apps segment offers Facebook, which enables people to share, discuss, discover, and connect with interests; Instagram, a community for sharing photos, videos, and private messages, as well as feed, stories, reels, video, live, and shops; Messenger, a messaging application for people to connect with friends, family, communities, and businesses across platforms and devices through text, audio, and video calls; and WhatsApp, a messaging application that is used by people and businesses to communicate and transact privately. The Reality Labs segment provides augmented and virtual reality related products comprising consumer hardware, software, and content that help people feel connected, anytime, and anywhere. The company was formerly known as Facebook, Inc. and changed its name to Meta Platforms, Inc. in October 2021. The company was incorporated in 2004 and is headquartered in Menlo Park, California

Zomedica stock logo

Zomedica NYSEAMERICAN:ZOM

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system. It also provides therapeutic products, including PulseVet electrohydraulic shockwave therapy platform; and Assisi Loop line of products, including the Assisi Loop, Assisi Loop Lounge, and DentaLoop devices that treat pain and inflammation through delivery of targeted pulsed electromagnetic field focused energy. The company has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for the development of a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. is headquartered in Ann Arbor, Michigan.